SUD 0.00% 4.2¢ suda pharmaceuticals ltd

ZolpiMist, page-11

  1. 2,412 Posts.
    lightbulb Created with Sketch. 64
    About our focus—Aytu is different

    Aytu is not a traditional research company. By acquiring or licensing approved, commercialized products and late-stage development therapeutics, we bring novel and needed treatments to market and to the millions of patients that need them. Novel products that can really help people feel better—and these products can make an impact today on patients’ health and well-being.

    Improving virility, suppressing severe cough and delivering better sleep

    Aytu is unique in our outlook toward the products we stand behind. And we are advancing unique therapeutics and diagnostics to improve and enhance vitality, reproductive health, severe cough and insomnia.
    Last edited by borisboy: 18/03/19
 
watchlist Created with Sketch. Add SUD (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.